Enamel matrix derivative (EMD; Emdogain) vs placebo or control
Change in gingival recession (REC) · Patients affected by chronic, aggressive, or early onset periodontitis, with intrabony defects having an intrabony component of at least 3…
Enamel matrix derivative (EMD; Emdogain) showed no clear difference in change in gingival recession (REC) compared with placebo or control (same surgical or non-surgical intervention… (low certainty).
1 finding from 1 review
- Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects 2009 · Cochrane All outcomes1 year (time-points 1, 5 and 10 years planned)MD 0.02 [-0.3, 0.3]6 studies · 302 participantsLow